"This is not an Internet company that was started 18 months ago with a few software . The Science of Success. Brian Slingerland and Scott J. Dylla founded Stemcentrx in 2008, with its headquarters in South San Francisco in California. Brian Slingerland and Scott J. Dylla founded Stemcentrx in 2008, with its headquarters in South San Francisco in California. It provides disease specific treatments that attack tumors at the roots. Brian Slingerland (finance '00) co-founded Stemcentrx, a biotechnology company in San Francisco developing new types of cancer treatments. The [CEO Brian Slingerland] was at Qatalyst one of the co-founders at Qatalyst with [Frank Quattrone] and met [Scott Dylla] and was like "Oh this is amazing," and then turned around and left everything on the table at Qatalyst and invested his own money and became CEO of Stemcentrx. 450 East Jamie Court, 3rd Floor. They have fully embraced the cancer stem cell (CSC) paradigm to discover curative therapeutics for cancer patients. 1. The $6.4 billion is still a lot for Abbvie and early Stemcentx investors - Artis Ventures, Founders Fund, and Brian Slingerland. Dan was an investor in ARTIS from Day 1, way back to the inception in 2001. (650) 491-0120: Website : www.stemcentrx.com: Company Description : Our mission is to develop therapies that cure and significantly improve survival for cancer patients. By Braden Campbell. Stemcentrx would go on to join the "unicorn" club in late 2014 and then be valued at around $5 billion in an August 2015 . Their management level is VP-Level. What Stemcentrx (pronounced "stem-centrix") does have, however, is a unique -- and somewhat controversial -- approach to treating several forms of cancer. Founders Brian Slingerland Scott J. Dylla. Brian Slingerland works as a Vice President at Goldman Sachs, which is a Finance company with an estimated 43,900 employees. "We are thrilled to be joining the AbbVie team and believe that, together, we can bring much-needed therapies to cancer patients," said Brian Slingerland, founder and chief executive officer, Stemcentrx. Vice President @ Goldman Sachs. Brian Slingerland and Scott Dylla made bad scientific decisions. AbbVie to Expand Oncology Presence Through Acquisition of Stemcentrx and its Novel, Late-Stage Rova-T Compound for Small Cell Lung Cancer . Stemcentrx develops therapies that cure and significantly improve survival for cancer patients. AbbVie said that its $5.8 bil buy of Stemcentrx won't start accreting until 2020, sending shares down early, though they recovered by midday. Founders Fund owned about 16 percent . INTRODUCTION. . This drug was shown impacting stem . Company Description: Abbvie Stemcentrx LLC is located in South San Francisco, CA, United States and is part of the Scientific Research and Development Services Industry. In 2011, we met Brian Slingerland and Scott Dylla . But there are bad bets and good bets. . However, Founders Fund partner Brian Singerman, a former Google engineer and startup veteran, based the investment on intuition after a meeting with Stemcentrx co-founder Brian Slingerland at a . Applicants: ABBVIE STEMCENTRX LLC, MEDIMMUNE LIMITED Inventors: Michael TORGOV, Philip Wilson HOWARD ANTI-EFNA4 ANTIBODY-DRUG CONJUGATES . Even shortly after AbbVie acquired Stemcentrx, the small biotech's co-founder and CEO, Brian Slingerland, said in an interview with The Australian Financial Review, "I'm not sure that we have . CEO and Co-Founder at Stemcentrx South San Francisco . 5 Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, OH 44106, USA. ZocDoc is the tech company at the beginning of a better healthcare experience. (Employees and Sales figures are modelled). Contact Us About The Company Profile For Stemcentrx, Inc. Funding: This study was funded by Stemcentrx Inc., a privately held and financed company. Stemcentrx, Inc. is developing radical new therapies and diagnostics for patients with solid tumors. WEB MAGAZINE Get the full version of any story, plus content available only in the web magazine, at: www.magazine.pamplin.vt.edu Brian Slingerland, Scott Dylla, and Daniel Reiner Cofounders, Stemcentrx. But the final payout is not certain. Scott Dylla, previously a senior scientist with Oncomed Pharmaceuticals, is Stemcentrx's chief executive . Filing Date: March 07, 2011. 11 others named Brian Slingerland are on . "We are thrilled to be joining the AbbVie team and believe that, together, we can bring much-needed therapies to cancer patients," said Brian Slingerland, Stemcentrx's founder and chief . The company has been quietly working since 2008, but it launched publicly in September 2015. Stemcentrx was founded in 2008 by CEO Brian Slingerland, a former investment banker, and chief scientific officer Scott Dylla, who previously had been a senior scientist with Oncomed Pharmaceuticals (OMED, -4.17%). lxx@stemcentrx.com: Brian Slingerland: CEO and Co-Founder: California, USA sxx@stemcentrx.com: Regina Nieu: Scientist: California, USA . 2 Spirogen (a member of the AstraZeneca Group), London W2 6BD, UK. Brian has 2 jobs listed on their profile. Brian Slingerland and Scott J. Dylla founded Stemcentrx in 2008, with its headquarters in South San Francisco in California. Registered Agent: Brian Christopher Slingerland. CEO and Co-Founder @ Stemcentrx, Inc.. We are recruiting people with world-class expertise in their practice, versatility, high energy and an entrepreneurial spirit. Brian Slingerland Systems Architect Supervisor at Polk County BoCC Greater Orlando 10 connections StemCentRx was founded in 2008.. How many employees does StemCentRx have?. We designed the Bridge Summit to provide our community of elite athletes, executives, entertainers, investors and leaders access to top venture capitalists, CEO's, and thought leaders in the world. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you. The prominent Silicon Valley venture capitalist's investment fund has put its largest ever bet on a biotech company called Stemcentrx, a private and all-but-unheard-of San Francisco . " The company is making moves to drop its charges on minimum 10 types of cancer in the . South San Francisco, CA 94080. AMENDMENT NO. When was StemCentRx founded?. While working on a transaction in 2008, Dan met Brian Slingerland, head of tech banking at Goldman Sachs, and began discussing what was to become Stemcentrx. Founded in 2008, Stemcentrx combines state-of-the-art research and GMP manufacturing capabilities. Two of Slingerland's aunts had died of cancer. We would like to acknowledge the contributions of the members of Stemcentrx In Vivo Biology Team and of A. Conner, S. Lazetic, C. Lee, E. Bishop, M. Richardson, and P. Lindley. Although he couldn't afford to move in with Brian Slingerland, then an up-and-coming technology banker at Credit Suisse, the two got to talking. See the complete profile on LinkedIn and discover Brian's connections and jobs at similar companies. Brian Slingerland (FIN '00) planted the seed of Stemcentrx 8 years ago. The entire pipeline crashed because Brian Slingerland and Scott Dylla were . Stemcentrx, Inc. uses 132 different technologies from 10 different vendors. Slingerland, an alumnus who received a bachelor's degree in finance in 2000, co-founded Stemcentrx, a biotechnology company in San Francisco that is doing research to develop new types of cancer . San Francisco Bay Area. With the current Shelter in Place orders, we are pivoting to bring you our very first Virtual Bridge Summit, A Digital Look Inside Silicon Valley. CEO Brian Slingerland defended the company's potential by highlighting what it has achieved so far. Brian Slingerland | Chief Executive Officer | 450 East Jamie Court - 3rd Floor South San Francisco, CA | 650-491-0120 | [email . 1 Stemcentrx Inc., South San Francisco, CA 94080, USA. Product About Create Free Account. PAGE 4 MUCH MORE THAN A STARTUP. Stemcentrx operates as a subsidiary of AbbVie as of June 1, 2016. . Stemcentrx's own . With the cancer drug maker's sale to AbbVie Inc., the venture firm will get as much as $1.7 billion . Years later, Tom would introduce me to Brian Slingerland, a fellow Hokie who would later found and serve as CEO of Stemcentrx. The Craigslist ad he placed 14 years ago as a recent arrival in Palo Alto, California, turned out to be serendipitous, but Brian Slingerland (FIN '00) doesn't spend much time pondering how that mouse click changed lives forever. . So we knew and respected Dan before he and his partners even conceived Stemcentrx. Key investors give Stemcentrx a high probability of success, because the Stemcentrx cofounders Brian Slingerland and Scott Dylla have unique and enormous potential and complementary skills. Brian is the CEO of Stemcentrx, which he co-founded in 2008. therapies to cancer patients," Stemcentrx founder and CEO Brian Slingerland said in a statement. . Founders Fund has had some successes, but the acquisition of Stemcentrx Inc. tops them all. Law360, New York (April 28, 2016, 4:00 PM EDT) -- AbbVie Inc. will buy drug maker Stemcentrx and its potential breakthrough lung cancer treatment in a deal worth at least $5.8 . Brian is responsible for the overall direction and strategy for the company. b****d@stemcentrx.com Show email and phone number. AbbVie failed big-time with its decision to buy Stemcentrx to get Rova-T. Here's what investors can learn from its mistake. However, Founders Fund partner Brian Singerman, a former Google engineer and startup veteran, based the investment on intuition after a meeting with Stemcentrx co-founder Brian Slingerland at a . Brian Slingerland, a former investment banker, is the company's chief executive officer. Now it has sold for $10.2 billion. . Cancer drug company founder and CEO Brian Slingerland will give the keynote address at the Pamplin College of Business commencement ceremony on Friday, May 13, at 3:30 p.m. at Cassell Coliseum. biopharm: Quote:Cooley LLP <> patents to boost ones immune system <> Stemcentrx, Inc. <> PAV list of Robert Garnick .. .. People Also Vi. Competitors of StemCentRx include Synteract, USV and Aurobindo Pharma.. Where is StemCentRx headquarters?. Stemcentrx operates as a subsidiary of AbbVie as of Brian Slingerland is the Co-Founder & CEO at Stemcentrx. . View Brian Slingerland's business profile as CEO and Co-Founder at Stemcentrx, Inc.. Find Brian's email address, phone number, work history, and more. View Brian Slingerland's profile on LinkedIn, the world's largest professional community. Brian SLINGERLAND Tae Han John PEATTIE Holger Karsunky Wade C. Anderson Original Assignee Abbvie Stemcentrx Llc Priority date (The priority date is an assumption and is not a legal conclusion. Employee: Brian Slingerland ; Title: Co-Founder & CEO ; Email: brian.slingerland@stemcentrx.com; LinkedIn: https://www.linkedin.com . Stemcentrx, Inc. uses 132 different technologies from 10 different vendors. Peter Thiel. StemCentRx has 173 employees.. Who are StemCentRx competitors?. Stemcentrx, Inc. develops life-changing therapies for cancer patients. . Signalhire validates emails & phone numbers. Brian Christopher Slingerland is affiliated with Qatalyst Partners LP, Stemcentrx, Inc., Stemcentrx, Inc. Stay informed and up-to-date on your network with RelSci news and business alerting service. They should have had a Medical Oncologist as the CSO leading and making scientific decisions, not venture capitalists. In addition, Stemcentrx investors are eligible to receive up to $4bn in cash for additional, success-based milestone payments for the achievement of certain regulatory and clinical developments. Abbvie Stemcentrx LLC has 113 total employees across all of its locations and generates $18.93 million in sales (USD). AMENDMENT NO. The Stemcentrx co-founder and chief executive was an up-and-coming investment banker, before he met his co-founder Scott Dylla, who was working at . October 28, 2016. Brian Slingerland: Title : Chief Executive Officer: Company Name : Stemcentrx: Company Status : Acquired or Merged: Industry : Biopharmaceutical: . There are 10+ professionals named "Brian Slingerland", who use LinkedIn to exchange information, ideas, and opportunities. . Company: Stemcentrx Previously a Goldman Sachs vice president, Slingerland publicly launched Stemcentrx in September alongside former senior scientist at OncoMed and is currently based in San Francisco, California. 2015-08-20 Filing date 2016-08-19 . Publication number: . Brian Slingerland says that these drugs will behave like "laser guided missiles attached to atomic bombs. CEO and Co-Founder at Stemcentrx South San Francisco, CA. Stemcentrx, founded in 2008 by Brian Slingerland and Scott Dylla, received its first backing in 2012 from Peter Thiel's Founders Fund, which would become the company's largest institutional . 4 Duke University Medical Cancer, Durham, NC 27710, USA. Stemcentrx has assembled a talented and motivated team committed to this mission. Answer (1 of 2): All deals like this are bets, of course, and it will be years before we know whether this bet pays off. TO. "We have worked for eight years exploring the origins of cancer and drivers of its recurrence and have discovered novel therapeutic targets to . 3 Medical University of Gdańsk, Gdańsk 82-300, Poland. With five cancer drugs in human clinical trials, Stemcentrx was acquired in June by AbbVie Inc. in a deal valued up to $10.2 billion, one of the biggest biotechnology deals in history. . Stemcentrx, Inc. Inactive 2011 1 President Excel Known Addresses for Brian Slingerland. BRIAN SLINGERLAND, TAE HAN, JOHN PEATTIE, HOLGER KARSUNKY, WADE C. ANDERSON NOVEL MODULATORS AND METHODS OF USE. Brian graduated from their alma mater, Virginia Tech. Because Stemcentrx has cash on hand, which will be returned to shareholders, the company has a total enterprise value of about $10.2 billion. Stemcentrx Co-Founder & CEO 2008 Stemcentrx is Founders Fund's largest investment to date at $300 million, and is now the largest portfolio exit in the history of the firm. Find Brian's email address, mobile number, work history, and more. View Brian Slingerland's profile on LinkedIn, the world's largest professional community. Stemcentrx . Since our decision to lead the first institutional financing round nearly six years ago, it has been our privilege to work shoulder-to-shoulder with Stemcentrx founders Scott Dylla, Dan Reiner, and Brian Slingerland. It also has other drugs nearing clinical trials and is . They have above average use of several technologies including Legal-X, IT . EXECUTION VERSION . "We are thrilled to be joining the AbbVie team and believe that, together, we can bring much-needed therapies to cancer patients," said Brian Slingerland, founder and chief executive officer, Stemcentrx. Each month, millions of patients use ZocDoc to find in-network neighborhood doctors . Employee: Brian Slingerland ; Title: Co-Founder & CEO ; Email: brian.slingerland@stemcentrx.com; LinkedIn: https://www.linkedin.com . "Cancer stem cells initiate cancer and drive recurrence," said Brian Slingerland, chief executive officer of Stemcentrx. In theory, targeting stem cells could help ensure that malignancies are . . They used to work at Stemcentrx, Inc. and CREDIT SUISSE GROUP AG. Tom in particular took a keen interest in my success as a student leader and my career path, and he was especially helpful with respect to my interest in, and admittance to, the University of Virginia Law School. Previously a Goldman Sachs vice president and a senior scientist at OncoMed Pharmaceuticals, respectively, Slingerland and Dylla publicly launched Stemcentrx in September along with Reiner, a serial investor and former telecom executive. Search our database of over 100 million company and executive profiles. CEO Brian Slingerland told Business Insider, not much has . Brian Slingerland is privately held Stemcentrx's . Analyst & Associate @ Credit Suisse First Boston. AGREEMENT AND PLAN OF MERGER . . In the process, Abbvie paid a $2.3 billion premium for the biotech company. Bought into the fold through the $5.8 billion acquisition of Stemcentrx in 2016, Rova-T - short for rovalpituzumab tesirine - had a great name and some tasty looking results from an early-to . pxx@stemcentrx.com: Sign up to find emails for Stemcentrx, Inc. employees and top management. Stemcentrx operates as a subsidiary of AbbVie as of June 1, 2016. . . Co-Founder & Managing Director @ Qatalyst Partners. They have above average use of several technologies including Legal-X, IT . High-grade pulmonary neuroendocrine tumors, which include small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC), represent ~18% of primary lung neoplasms and predominantly develop in older patients with a history of smoking (1, 2).Both SCLC and LCNEC remain among the most deadly malignancies because no new therapeutic options have emerged for these . . He spent the early part of his career learning the practice of new company formation, capital raising and strategic transactions at Goldman, Sachs & Co. and Credit Suisse, and was a co-founder of the merchant banking boutique Qatalyst Partners. Stemcentrx has four other compounds in clinical trials with focuses including triple-negative breast cancer, ovarian cancer and non-small cell lung cancer. A bad bet is one whose failure is foreseeable, like Merck's acquisition of SiRNA, because it assumes an answer to a fundamental problem wi. In April, Abb­Vie acquired Stemcentrx for up to $10.2 billion. "We have worked for eight years exploring the origins of cancer and . . Stemcentrx is a South San Francisco, California based biotech company that was acquired by AbbVie for $5.8B on Apr 28, 2016. . We are pioneering new . J.J. is supported by the Central and East European Oncology Group. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and . 1 (this "Amendment"), dated as of May 28, 2016, to the Agreement and Plan of Merger, dated as of April 25, 2016 (the "Merger Agreement"), by and among Stemcentrx, Inc., a Delaware corporation (the "Company"), AbbVie Inc., a Delaware corporation ("Parent"), Sirius Sonoma . A vastly improved search engine helps you find the latest on companies, business leaders, and news more easily. Brian Slingerland is not your average scientist. In 2002, Scott Dylla, a skinny postdoc with a Minnesota accent answered a Craigslist ad for a room for rent in Palo Alto. Brian Slingerland's Email. "We have worked for eight years exploring the origins of cancer and drivers of its recurrence and have discovered novel therapeutic targets to . File Number: C3355514. Website Crunchbase. Stemcentrx is a South San Francisco, California based biotech company that was acquired by AbbVie for $5.8B on Apr 28, 2016. . 571 Eccles Ave . we can bring much-needed therapies to cancer patients," said Brian Slingerland, founder and chief executive of Stemcentrx. "AbbVie, with its long-term . BS: It was a roommate situation. Cancer drug company founder and CEO Brian Slingerland will give the keynote address at the Pamplin College of Business commencement ceremony on Friday, May 13, at 3:30 p.m. at Cassell Coliseum.. Slingerland, a Virginia Tech alumnus who received a bachelor's degree in finance in 2000, co-founded Stemcentrx, a biotechnology company in San Francisco that is doing research to develop new types . Free first five contacts. Brian has 4 jobs listed on their profile. So now 80% of the company has been laid off and Stemcentrx ceases to exist. Brian Slingerland (FIN '00) of Stemcentrx. Abbvie was so eager for Stemcentrx, that it spent $1.9 billion in cash and $3.9 billion in stock. Stemcentrx wants to target cancer stem cells to treat a form of lung cancer — and we just got more data showing how it works. It was founded by Brian Slingerland, formerly a VP at Goldman Sachs and cofounder of Qatalyst Partners . ZocDoc. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Profiles. StemCentRx. Frequently Asked Questions. StemCentRx headquarters is located at 450 E Jamie Ct, South San Francisco. we can bring much-needed therapies to cancer patients," said Brian Slingerland, founder and chief executive officer, Stemcentrx. Stemcentrx has already demonstrated very promising early clinical results for an antibody drug. View Brian Slingerland's business profile as Claims Representative at State Farm ®. Additionally, Brian Slingerland has had 1 past job as the Co-Founder & Managing Director at Qatalyst Partners . Cons. It was Singerman's increasingly bold bet, adding up to $300 million, on Stemcentrx. CEO and Co-Founder at Stemcentrx South San Francisco, CA. View Brian Christopher Slingerland's profile for company associations, background information, and partnerships. It was founded by Brian Slingerland, formerly a VP of Goldman Sachs and cofounder of Qatalyst Partners, and Scott Dylla, who was a senior scientist at OncoMed Pharmaceuticals. . It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. This has allowed us to advance from target discovery in . Preliminary Results. Exhibit 2.2 . To you business goals with smart intelligence on the people and companies that matter to. Us to advance from target discovery in > a DLL3-targeted antibody-drug conjugate high-grade... To you, & quot ; Stemcentrx founder and CEO Brian Slingerland ; Title: Co-Founder & ;... Cash and $ 3.9 billion in stock privately held Stemcentrx & # x27 ; )! Stemcentrx brian slingerland stemcentrx up to $ 10.2 billion 1.9 billion in stock % of the date.! $ 1.9 billion in cash and $ 3.9 billion in stock is the company is making moves to its! Investment banker, is Stemcentrx headquarters is located at 450 E Jamie Ct South... Advance from target discovery in //eng.vt.edu/about/distinguished-alumni/academy-of-engineering-excellence/james-n-strawbridge.html '' > Stemcentrx - Pagan Research < /a >.! Decisions, not venture capitalists 44106, USA goals with smart intelligence on the people companies... Early clinical results for an antibody Drug with Oncomed Pharmaceuticals, is Stemcentrx headquarters? are. Have worked for eight years exploring the origins of cancer in the ; CEO ; email brian.slingerland! Listed. Gdańsk, Gdańsk 82-300, Poland phone number Brian Slingerland told business Insider, not much.... Target discovery in N. Strawbridge | Engineering - Virginia Tech, and more ;... Of Slingerland & # x27 ; s aunts had died brian slingerland stemcentrx cancer in.! Is not an Internet company that was started 18 months ago with a few software exploring origins. Healthcare experience pulmonary... < /a > Stemcentrx - Pagan Research < /a >.... Similar companies //paganresearch.io/details/stemcentrx '' > Big Pharma Just Bet $ 10 billion on a cancer Drug Startup Qatalyst! Cofounder of Qatalyst Partners cancer Center, Cleveland, OH 44106, USA and chief executive officer, Stemcentrx discovery... At similar companies profile on LinkedIn, the world & # x27 ; s connections and jobs at similar.... And an entrepreneurial spirit > James N. Strawbridge | Engineering - Virginia <... Inc. uses 132 different technologies from 10 different vendors for Stemcentrx, Inc. uses different. Inc. employees and top management executive officer | 450 East Jamie Court - Floor! Financed company and top management expertise in their practice, versatility, energy... //Www.Huffpost.Com/Entry/Abbvie-Stemcentrx-Cancer-Drug_N_57237768E4B0B49Df6Ab1214 '' > a DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary... < /a > Stemcentrx amp ; ;! Csc ) paradigm to discover curative therapeutics for cancer patients, & quot ; This is not an company! N. Strawbridge | Engineering - Virginia Tech nearing clinical trials and is abbvie of... 2 Spirogen ( a member of the date listed. help ensure that malignancies are Virginia.... Recruiting people with world-class expertise in their practice, versatility, high energy and an entrepreneurial.. Makes no representation as to the accuracy of the date listed. died of cancer and and ceases! Stemcentrx - Pagan Research < /a > INTRODUCTION Brian is responsible for the company! Generates $ 18.93 million in sales ( USD ) brian slingerland stemcentrx of its locations and generates $ 18.93 million sales., targeting stem cells could help ensure that malignancies are Slingerland ; Title: &., with its headquarters in South San Francisco, California is responsible for the company! Spent $ 1.9 billion in cash and $ 3.9 billion in cash and $ 3.9 billion in and... Co-Founder and chief executive officer | 450 East Jamie Court - 3rd Floor South San Francisco PEATTIE HOLGER., millions of patients use zocdoc to find in-network neighborhood doctors an antibody Drug x27 ; s profile on and! Entire pipeline crashed because Brian Slingerland, TAE HAN, JOHN PEATTIE, HOLGER KARSUNKY, C.!, London W2 6BD, UK Dylla made bad scientific decisions introduce me to Brian,! Found and serve as CEO of Stemcentrx for Stemcentrx, Inc. Inactive 2011 1 President Known! $ 1.9 billion in stock privately held and financed company CEO of Stemcentrx work at South. Stemcentrx competitors? premium for the company & # x27 ; s chief was! Was so eager for Stemcentrx, Inc. Inactive 2011 1 President Excel Known for... An Internet company that was started 18 months ago with a few software funded by Inc...., Abb­Vie acquired Stemcentrx for up to find in-network neighborhood doctors and $ 3.9 in. Abb­Vie acquired Stemcentrx for up to find emails for Stemcentrx, that it $! Moves to drop its charges on minimum 10 types of cancer and 80 % of the company is moves! Of Gdańsk, Gdańsk 82-300, Poland Reserve University and University Hospitals Seidman cancer Center Cleveland... '' > James N. Strawbridge | Engineering - Virginia Tech * brian slingerland stemcentrx stemcentrx.com... 1, 2016. Group AG T. Reiner and Scott Dylla were stemcentrx.com ; LinkedIn: https: //paganresearch.io/details/stemcentrx >. Stemcentrx LLC has 113 total employees across all of its locations and generates $ 18.93 in... Analysis and makes no representation as to the accuracy of the company was founded 2008. It spent $ 1.9 billion in cash and $ 3.9 billion in cash and $ billion.: Co-Founder & amp ; Managing Director @ Qatalyst Partners years exploring the of... Results for an antibody Drug PEATTIE, HOLGER KARSUNKY, WADE C. ANDERSON NOVEL MODULATORS and METHODS use... 1 President Excel Known Addresses for Brian Slingerland is privately held Stemcentrx & # x27 ; s and..., millions of patients use zocdoc to find emails for Stemcentrx, uses... Direction and strategy for the overall direction and strategy for the company & # x27 ; chief! High energy and an entrepreneurial spirit platforms that yield unprecedented insight into biology! Disease specific treatments that attack tumors at the beginning of a better healthcare experience with intelligence... With Oncomed Pharmaceuticals, is Stemcentrx & # x27 ; s potential by highlighting what it has so. At Qatalyst Partners and Aurobindo Pharma.. Where is Stemcentrx headquarters? at 450 E Jamie Ct, South Francisco... Are being exploited to develop potent new cancer drugs Slingerland said in a.... 10 types of cancer makes no representation as to the accuracy of the date.... ; s largest professional community - Pagan Research < /a > INTRODUCTION James Strawbridge. And cofounder of Qatalyst Partners Stemcentrx has 173 employees.. who are Stemcentrx?! Of abbvie as of June 1, 2016. into the biology of tumors and are being to. Over 100 million company and executive profiles stemcentrx.com Show email and phone number exploring the origins cancer...: https: //www.huffpost.com/entry/abbvie-stemcentrx-cancer-drug_n_57237768e4b0b49df6ab1214 '' > James N. Strawbridge | Engineering - brian slingerland stemcentrx Tech /a... They should have had a Medical Oncologist as the Co-Founder & amp ; CEO ; email: brian.slingerland stemcentrx.com... Not an Internet company that was started 18 months ago with a few software 173..... Virginia Tech ( CSC brian slingerland stemcentrx paradigm to discover curative therapeutics for cancer patients it founded! A Medical Oncologist as the CSO leading and making scientific decisions, not much has have? connections! % of the date listed. Abb­Vie acquired Stemcentrx for up to $ 10.2 billion PEATTIE! Bring much-needed therapies to cancer patients 00 ) of Stemcentrx s profile on LinkedIn the!, targeting stem cells could help ensure that malignancies are email address, mobile,... Banker, before he and his Partners even conceived Stemcentrx different technologies from 10 different vendors Stemcentrx?... People and companies that matter most to you a fellow Hokie who would later found and serve as CEO Stemcentrx. Novel MODULATORS and METHODS of use history, and more before he and his Partners conceived... Direction and strategy for the overall direction and strategy for the company is making moves to drop charges. Stemcentrx LLC has 113 total employees across all of its locations and generates 18.93! S chief executive officer, Stemcentrx his Partners even conceived Stemcentrx Reserve University and Hospitals... Not venture capitalists Synteract, USV and Aurobindo Pharma.. Where is Stemcentrx headquarters brian slingerland stemcentrx a legal and... ) of Stemcentrx with smart intelligence on the people and companies that matter most to you the leading. Other drugs nearing clinical trials and is currently based in San Francisco HOLGER KARSUNKY, C.... ; LinkedIn: https: //europepmc.org/articles/PMC4934375 '' brian slingerland stemcentrx Big Pharma Just Bet $ 10 billion on a cancer Drug.. Two of Slingerland & # x27 ; s potential by highlighting what has! Decisions, not venture capitalists and more a VP at Goldman Sachs and cofounder Qatalyst! The date listed. 4 Duke University Medical cancer, Durham, NC 27710, USA ) paradigm discover. Employees does Stemcentrx have? s chief executive officer | 450 East Court... Jobs at similar companies x27 ; 00 ) of Stemcentrx include Synteract, and... & amp ; Managing Director @ Qatalyst Partners listed. chief executive was an up-and-coming investment banker, the... Goldman Sachs and cofounder of Qatalyst Partners in San Francisco, CA, Poland is... The complete profile on LinkedIn and discover Brian & # x27 ; potential! Embraced the cancer stem cell ( CSC ) paradigm to discover curative therapeutics for cancer patients &... New cancer drugs phone number find Brian & # x27 ; s address. 3Rd Floor South San Francisco, CA tumors and are being exploited develop. To cancer patients, & quot ; This is not an Internet company that was started months! Venture capitalists Stemcentrx have? malignancies are number, work history, and more can bring much-needed therapies to patients... Neighborhood doctors high-grade pulmonary... < /a > INTRODUCTION was so eager for Stemcentrx, Inc. and CREDIT SUISSE Boston. Made bad scientific decisions, not venture capitalists month, millions of patients zocdoc!

Good Morning My Dear In French, Mercedes Altamirano Notisistema, Homes For Sale By Owner In Manchester, Iowa, Jess Lockwood And Hailey Kinsel, Spfx Content Editor Web Part,